Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results

被引：0
|
作者：
Pujol, N. [1 ]
Pace-Loscos, T. [1 ]
Schiappa, R. [2 ]
Gautier, M. [1 ]
Chand, M. E. [1 ]
Levi, J. M. Hannoun [3 ]
机构：
[1] Antoine Lacassagne Canc Ctr, Nice, France
[2] Univ Cote Azur, Antoine Lacassagne Canc Ctr, Nice, France
[3] Univ Cote Azur, Ctr Antoine Lacassagne, Dept Radiotherapy, Nice, France
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2540
引用
收藏
页码：E242 / E242
页数：1
相关论文
共 50 条
  • [41] Phase II Trial of image-based HDR interstitial brachytherapy for previously irradiated gynecological cancer
    Olarte, A.
    Valtuena, G.
    Cambeiro, M.
    Moreno, M.
    Aristu, J. J.
    Arbea, L.
    Ramos, L.
    Barbes, B.
    Azcona, D.
    Martinez-Monge, R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S149 - S149
  • [42] HDR monotherapy brachytherapy for localised prostate cancer
    Hoskin, P. J.
    Bownes, P.
    Bryant, L.
    Ostler, P.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S7 - S7
  • [43] HDR Brachytherapy Combined to EBRT and ADT for Prostate Cancer: Analysis of Toxicities and Quality of Life in a Phase 2 Trial
    Tetreault, A.
    Nguyen-Huynh, T. V.
    Vincent, F.
    Saad, F.
    Benoit, N.
    Fortin, B.
    Lambert, C.
    Jolicoeur, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E214 - E215
  • [44] A single centre experience of HDR brachytherapy as salvage treatment for relapsed prostate cancer
    Dugdale, E.
    Slevin, F.
    Rodda, S.
    Bottomley, D.
    Carey, B.
    Smith, J.
    Hulson, O.
    Adiotomre, E.
    Mason, J.
    Bownes, P.
    Henry, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1249 - S1250
  • [45] Single dose HDR brachytherapy is safe for low-risk prostate cancer
    Hoskin, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S39 - S39
  • [46] Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial
    Gomez-Iturriaga, Alfonso
    Buchser, David
    Mayrata, Esther
    San Miguel, Inigo
    Gonzalez, Alba
    Suarez, Fernan
    Martinez-Indart, Lorea
    Minguez, Pablo
    Espinosa, Jose
    Perez, Fernando
    Cacicedo, Jon
    Casquero, Francisco
    RADIOTHERAPY AND ONCOLOGY, 2020, 146 : 16 - 20
  • [47] Combined fast neutron irradiation and permanent prostate brachytherapy in intermediate and poor risk prostate cancer: Expanded results of Phase II trial
    Patel, R.
    Forman, J. D.
    Cher, M.
    Perry, D.
    Bolton, S.
    Zuniga, C.
    Joiner, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S360 - S361
  • [48] Phase I/II trial of HDR-brachytherapy boosted comprehensive IMRT for intermediate-risk adenocarcinoma of the prostate
    Hagan, M.
    Todor, D.
    Dogan, N.
    Wu, Y.
    Anscher, M.
    Arthur, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S363 - S363
  • [49] Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial
    Zilli, Thomas
    Franzese, Ciro
    Bottero, Marta
    Giaj-Levra, Niccolo
    Forster, Robert
    Zwahlen, Daniel
    Koutsouvelis, Nikolaos
    Bertaut, Aurelie
    Blanc, Julie
    D'agostino, Giuseppe Roberto
    Alongi, Filippo
    Guckenberger, Matthias
    Scorsetti, Marta
    Miralbell, Raymond
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : 83 - 86
  • [50] Single fraction urethra-sparing prostate cancer SBRT: phase i results of the ONE SHOT trial
    Verane, Achard
    Achard, Verane
    Franzese, Ciro
    Giaj-Levra, Niccolo
    Forster, Robert
    Zwahlen, Daniel
    Koustouvelis, Nikolaos
    Bertaut, Aurelie
    Blanc, Julie
    Alongi, Filippo
    Guckenberger, Matthias
    Scorsetti, Marta
    Miralbell, Raymond
    Zilli, Thomas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (12) : 1142 - 1142
12345